US Stock MarketDetailed Quotes

WINT Windtree Therapeutics

Watchlist
  • 0.3202
  • -0.0048-1.48%
Close Dec 20 16:00 ET
  • 0.3301
  • +0.0099+3.09%
Post 20:01 ET
2.88MMarket Cap-0.01P/E (TTM)

About Windtree Therapeutics Company

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Company Profile

SymbolWINT
Company NameWindtree Therapeutics
Listing DateAug 8, 1995
Issue Price3.50
Founded1992
CEOMr. Jed A. Latkin
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address2600 Kelly Road,Suite 100
CityWarrington
ProvincePennsylvania
CountryUnited States of America
Zip Code18976-3622
Phone1-215-488-9300
Websitehttp://www.windtreetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Jed A. Latkin
  • Director, President and Chief Executive Officer
  • --
  • Eric Curtis
  • Senior Vice President and Chief Operating Officer
  • 451.73K
  • Jamie McAndrew
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • --
  • Dr. Steven G. Simonson, M.D.
  • Senior Vice President and Chief Medical Officer
  • 491.73K
  • Craig E. Fraser
  • Chairman of the Board
  • 693.63K
  • Saundra Pelletier
  • Independent Director
  • --
  • Dr. Mark Strobeck, PhD
  • Lead Independent Director
  • 32.34K
Heat List
US
Overall
Symbol
Price
% Chg

No Data